Numerous genetic mutations are associated with certain types of hereditary cancer. Genetic testing using next-generation sequencing technology allows for the analysis of multiple genes at one time (panel testing), and these panels are commercially available. Using a multigene panel, physicians are able to identify important mutations beyond single-gene mutations. To be beneficial, multigene panel testing must provide clinically relevant and actionable data that will result in changes in patients' treatment and surveillance regimens.
This resource is more relevant to the oncology specialist.
Experts from the disciplines listed below have tagged this resource as fulfulling genomic competencies.